CASI Pharmaceuticals, Inc. ( CASI) - Key Metrics
Stock symbol CASI is outdated, potentially delisted? Maybe it is available on other exchange?
CASI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | $0.40 | -$0.69 | ? | ? |
| 2024Q4 | $0.86 | -$0.93 | ? | ? |
| 2024Q3 | $0.51 | -$0.55 | ? | ? |
CASI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | -0.78 |
| 2024Q4 | ? | -0.76 |
| 2024Q3 | ? | -2.81 |
CASI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
| 2024Q4 | ? | ? |
| 2024Q3 | ? | ? |
CASI
Price: $0.21
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 21900
Ebitda: -1.6 millionMarket Capitalization: 3.2 million